Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06192576
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2023-12-20
Brief Title:
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency ASMD
Sponsor:
Organization:
Sanofi